Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,505 | 185 | 96.3% |
| Education | $95.75 | 13 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $246.94 | 19 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $227.49 | 12 | $0 (2019) |
| Amgen Inc. | $221.96 | 16 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $185.69 | 18 | $0 (2018) |
| Novo Nordisk Inc | $169.66 | 15 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $158.53 | 14 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $155.77 | 11 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $152.54 | 13 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $140.28 | 10 | $0 (2018) |
| Astellas Pharma US Inc | $139.45 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.80 | 1 | Vital Connect, Inc ($24.80) |
| 2022 | $14.95 | 1 | ABBVIE INC. ($14.95) |
| 2020 | $28.17 | 2 | Amarin Pharma Inc. ($28.17) |
| 2019 | $382.09 | 28 | Amgen Inc. ($63.05) |
| 2018 | $1,029 | 77 | Novartis Pharmaceuticals Corporation ($203.22) |
| 2017 | $1,122 | 89 | Merck Sharp & Dohme Corporation ($129.22) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/06/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: CARDIOLOGY | ||||||
| 02/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Cardiovascular | ||||||
| 04/16/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Cardiovascular | ||||||
| 10/29/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Motegrity (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: Lower GI | ||||||
| 06/27/2019 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2019 | iRhythm Technologies, Inc. | ZIO Patch (Device) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/18/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Neuroscience | ||||||
| 06/18/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: RESPIRATORY | ||||||
| 06/17/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 06/10/2019 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/04/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: UROLOGY | ||||||
| 06/03/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/29/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $14.99 | General |
| 05/14/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $14.46 | General |
| Category: Cardiovascular | ||||||
| 05/14/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $0.98 | General |
| Category: RESPIRATORY | ||||||
| 05/07/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET XR, STEGLATRO | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/02/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Neuroscience | ||||||
| 04/29/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/09/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: UROLOGY | ||||||
| 04/04/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: Diabetes | ||||||
| 03/29/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.92 | General |
| Category: AED | ||||||
| 03/26/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Neuroscience | ||||||
| 03/20/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 372 | 859 | $139,065 | $43,273 |
| 2022 | 10 | 505 | 1,073 | $155,483 | $50,345 |
| 2021 | 17 | 1,126 | 1,891 | $235,952 | $61,475 |
| 2020 | 35 | 2,702 | 5,232 | $555,583 | $164,011 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 345 | $89,355 | $26,886 | 30.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 24 | 102 | $17,034 | $4,482 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 56 | $10,024 | $3,076 | 30.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 15 | $7,380 | $2,147 | 29.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 92 | 250 | $5,750 | $2,069 | 36.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 20 | 20 | $2,980 | $1,439 | 48.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 18 | 18 | $1,980 | $1,365 | 68.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 40 | 40 | $2,560 | $1,157 | 45.2% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 13 | 13 | $2,002 | $653.64 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 128 | 338 | $83,294 | $28,090 | 33.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 65 | 228 | $38,076 | $10,292 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 93 | $15,927 | $5,328 | 33.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 37 | 38 | $4,168 | $2,662 | 63.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 40 | 41 | $2,612 | $1,128 | 43.2% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 26 | 26 | $1,326 | $946.40 | 71.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 15 | 15 | $2,310 | $758.84 | 32.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 103 | 254 | $5,842 | $742.01 | 12.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 11 | 22 | $1,496 | $358.16 | 23.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 16 | 18 | $432.00 | $40.00 | 9.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 287 | 540 | $112,916 | $35,287 | 31.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 128 | 304 | $50,768 | $8,156 | 16.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 110 | 154 | $24,166 | $8,070 | 33.4% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 44 | 44 | $4,708 | $2,923 | 62.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 17 | 17 | $4,920 | $2,176 | 44.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 269 | 434 | $9,982 | $1,274 | 12.8% |
About Dr. Albert Mims, M.D
Dr. Albert Mims, M.D is a Family Medicine healthcare provider based in Lake City, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609972314.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Albert Mims, M.D has received a total of $2,601 in payments from pharmaceutical and medical device companies, with $24.80 received in 2024. These payments were reported across 198 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($2,505).
As a Medicare-enrolled provider, Mims has provided services to 4,705 Medicare beneficiaries, totaling 9,055 services with total Medicare billing of $319,105. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lake City, SC
- Active Since 09/16/2006
- Last Updated 11/19/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1609972314
Products in Payments
- ENTRESTO (Drug) $227.49
- Victoza (Drug) $132.87
- BYDUREON (Drug) $120.83
- JANUVIA (Drug) $117.68
- Prolia (Biological) $112.39
- FARXIGA (Drug) $96.13
- Aimovig (Biological) $89.57
- INVOKANA (Drug) $81.01
- JARDIANCE (Drug) $80.30
- XARELTO (Drug) $74.76
- TROKENDI XR (Drug) $73.98
- SOLIQUA (Drug) $66.67
- SPIRIVA RESPIMAT (Drug) $65.35
- Utibron (Drug) $64.11
- LONHALA MAGNAIR (Drug) $62.48
- MYRBETRIQ (Drug) $59.84
- Myrbetriq (Drug) $57.42
- STIOLTO (Drug) $57.08
- Livalo (Drug) $51.66
- Vascepa (Drug) $46.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lake City
Miguel Tepedino, Md, MD
Family Medicine — Payments: $71,706
Dr. Richard Wright, M.d, M.D
Family Medicine — Payments: $17,641
Ernest De Leon, Md, MD
Family Medicine — Payments: $17,392
Dr. David Moon, M.d, M.D
Family Medicine — Payments: $13,012
Dr. Daniel Decamps, M.d, M.D
Family Medicine — Payments: $11,529
Jean-Felert Cadet, M.d Mph, M.D MPH
Family Medicine — Payments: $5,750